C&R Research Inc. (KOSDAQ:359090)

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2019
Biotechnology	59.69B	55.10B	48.47B	43.17B	-
Biotechnology Growth	8.32%	13.68%	12.28%	-	-
Sale of Goods	-	-	-	-	622.00K
Other	-	-	-	-	106.76M
Provision of Services	-	-	-	-	27.10B
Total	59.69B	55.10B	48.47B	43.17B	27.20B
Total Growth	8.32%	13.68%	12.28%	58.70%	-

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2019
South Korea	59.28B	54.84B	47.42B	43.10B	27.06B
South Korea Growth	8.11%	15.63%	10.03%	59.28%	-
Overseas	404.15M	264.83M	1.08B	71.94M	144.44M
Overseas Growth	52.61%	-75.38%	1395.16%	-50.19%	-
Total	59.69B	55.10B	48.50B	43.17B	27.20B
Total Growth	8.32%	13.62%	12.34%	58.70%	-

Source: S&P Global Market Intelligence.